|
|
||||||||
Rotary Centre for Cardiovascular Research, School of Health Science, Griffith University Gold Coast Campus, Southport, Queensland 4217, Australia
Metabolic and
functional responses to extracellular
Mg2+ concentration
([Mg2+]o)
were studied in perfused rat heart. Elevations of
[Mg2+]o
from 1.2 to 2.4, 5.0, and 8.0 mM dose dependently reduced contractile function and myocardial oxygen consumption
(M
O2) up to 80%. Intracellular Mg2+ concentration
([Mg2+]i)
remained stable (0.45-0.50 mM) during perfusion with 1.2-5.0 mM
[Mg2+]o
but increased to 0.81 ± 0.14 mM with 8.0 mM
[Mg2+]o.
Myocardial ATP was unaffected by
[Mg2+]o,
phosphocreatine (PCr) increased up to 25%, and
Pi declined by up to 50%. Free
energy of ATP hydrolysis
(
GATP)
increased from
60 to
64 kJ/mol. Adenosine efflux declined
in parallel with changes in
M
O2 and
[AMP]. At comparable workload and
M
O2, the effects of
[Mg2+]o
on cytosolic free energy were mimicked by reduced extracellular Ca2+ concentration
([Ca2+]o)
or Ca2+ antagonism with verapamil.
Moreover, functional and energetic effects of
[Mg2+]o
were reversed by elevated
[Ca2+]o.
Despite similar reductions in preischemic function and
M
O2, metabolic and
functional recovery from 30 min of global ischemia was enhanced
in hearts treated with 8.0 mM
[Mg2+]o
vs. 2.0 µM verapamil. It is concluded that
1) 1.2-8.0 mM
[Mg2+]o
improves myocardial cytosolic free energy indirectly by reducing metabolic rate and Ca2+ entry;
2)
[Mg2+]i
does not respond rapidly to elevations in
[Mg2+]o
from 1.2 to 5.0 mM and is uninvolved in acute functional and metabolic
responses to
[Mg2+]o;
3) adenosine formation in rat heart
is indirectly reduced during elevated
[Mg2+]o;
and 4) 8.0 mM
[Mg2+]o
provides superior protection during ischemia-reperfusion
compared with functionally equipotent
Ca2+ channel blockade.
adenosine; calcium; cardioplegia; free energy of adenosine 5'-triphosphate hydrolysis; phosphorus-31 nuclear magnetic resonance spectroscopy; rat hearts
This article has been cited by other articles:
![]() |
A. J Flood, L. Willems, and J. P Headrick Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart Cardiovasc Res, July 1, 2002; 55(1): 161 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J Harrison, R. J Cerniway, J. Peart, S. S Berr, K. Ashton, S. Regan, G Paul Matherne, and J. P Headrick Effects of A3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart Cardiovasc Res, January 1, 2002; 53(1): 147 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Sharikabad, K. M. Ostbye, and O. Brors Increased [Mg2+]o reduces Ca2+ influx and disruption of mitochondrial membrane potential during reoxygenation Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2113 - H2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Sharikabad, K. M. Ostbye, T. Lyberg, and O. Brors Effect of extracellular Mg2+ on ROS and Ca2+ accumulation during reoxygenation of rat cardiomyocytes Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H344 - H353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peart and J. P. Headrick Intrinsic A1 adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2166 - H2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bellomo, J. P. Headrick, G. U. Silins, C. A. Paterson, P. S. Thomas, M. Gartside, A. Mould, M. M. Cahill, I. D. Tonks, S. M. Grimmond, et al. Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia Circ. Res., February 4, 2000; 86 (2): e29 - e35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |